| Primary |
| Hiv Infection |
79.1% |
| Antiretroviral Therapy |
9.3% |
| Pancreatic Carcinoma |
1.9% |
| Acquired Immunodeficiency Syndrome |
1.8% |
| Progressive Multifocal Leukoencephalopathy |
1.4% |
| Prophylaxis |
1.4% |
| Drug Use For Unknown Indication |
1.1% |
| Product Used For Unknown Indication |
1.0% |
| Prophylaxis Against Hiv Infection |
0.6% |
| Castleman's Disease |
0.5% |
| Hiv Test Positive |
0.5% |
| Hepatitis C Virus Test |
0.3% |
| Non-small Cell Lung Cancer |
0.3% |
| Squamous Cell Carcinoma |
0.3% |
| Infection Prophylaxis |
0.2% |
| Pulmonary Embolism |
0.2% |
|
| Drug Exposure During Pregnancy |
16.7% |
| Lipodystrophy Acquired |
9.0% |
| No Adverse Event |
7.7% |
| Hydronephrosis |
5.1% |
| Intra-uterine Death |
5.1% |
| Stillbirth |
5.1% |
| Ventricular Hypertrophy |
5.1% |
| Vomiting |
5.1% |
| Abortion Spontaneous |
3.8% |
| Dermatitis Bullous |
3.8% |
| Eyelid Function Disorder |
3.8% |
| Eyelid Ptosis |
3.8% |
| Hypospadias |
3.8% |
| Portal Hypertension |
3.8% |
| Sickle Cell Anaemia |
3.8% |
| Virologic Failure |
3.8% |
| Death |
2.6% |
| Drug Interaction |
2.6% |
| Genotype Drug Resistance Test Positive |
2.6% |
| Glucose-6-phosphate Dehydrogenase Deficiency |
2.6% |
|
| Secondary |
| Hiv Infection |
43.6% |
| Drug Exposure During Pregnancy |
24.9% |
| Drug Use For Unknown Indication |
12.8% |
| Antiretroviral Therapy |
2.1% |
| Hepatitis C |
2.1% |
| Prophylaxis Against Hiv Infection |
1.6% |
| Mycobacterium Avium Complex Infection |
1.2% |
| Progressive Multifocal Leukoencephalopathy |
1.2% |
| Nephrotic Syndrome |
1.1% |
| Pancreatitis Chronic |
1.1% |
| Candidiasis |
0.9% |
| Factor Ix Deficiency |
0.9% |
| Oral Candidiasis |
0.9% |
| Pain In Extremity |
0.9% |
| Stomatitis |
0.9% |
| Antiviral Prophylaxis |
0.8% |
| Pancreatic Carcinoma |
0.8% |
| Product Used For Unknown Indication |
0.8% |
| Hyperuricaemia |
0.7% |
| Retinal Vein Occlusion |
0.5% |
|
| Drug Exposure During Pregnancy |
12.2% |
| Vomiting |
12.2% |
| Polydactyly |
9.5% |
| Cryptorchism |
8.1% |
| Threatened Labour |
8.1% |
| White Blood Cell Count Decreased |
5.4% |
| Epilepsy |
4.1% |
| Premature Baby |
4.1% |
| Productive Cough |
4.1% |
| Pulmonary Embolism |
4.1% |
| Weight Increased |
4.1% |
| Glucose-6-phosphate Dehydrogenase Deficiency |
2.7% |
| Glycogen Storage Disease Type I |
2.7% |
| Loss Of Consciousness |
2.7% |
| Progressive External Ophthalmoplegia |
2.7% |
| Retinal Toxicity |
2.7% |
| Small For Dates Baby |
2.7% |
| Sudden Death |
2.7% |
| Urethral Discharge |
2.7% |
| Ventricular Septal Defect |
2.7% |
|
| Concomitant |
| Drug Use For Unknown Indication |
43.9% |
| Hiv Infection |
22.0% |
| Antiviral Prophylaxis |
7.3% |
| Asthma |
4.9% |
| Bipolar Disorder |
4.9% |
| Drug Dependence |
4.9% |
| Abnormal Behaviour |
2.4% |
| High Density Lipoprotein Decreased |
2.4% |
| Hiv Test Positive |
2.4% |
| Mental Disorder |
2.4% |
| Pain |
2.4% |
|
| Ventricular Septal Defect |
27.3% |
| Weight Increased |
18.2% |
| Drug Intolerance |
9.1% |
| Groin Abscess |
9.1% |
| Haemoglobin Decreased |
9.1% |
| Hepatitis C |
9.1% |
| Product Taste Abnormal |
9.1% |
| Respiratory Tract Congestion |
9.1% |
|
| Interacting |
| Antiretroviral Therapy |
80.0% |
| Chronic Obstructive Pulmonary Disease |
20.0% |
|
| Drug Interaction |
66.7% |
| Loss Of Consciousness |
33.3% |
|
